🏛️ Verified NIH Record • Updated 2025-01-22

Native Coronary Artery Instead of SAphenous Vein Graft Intervention for Treatment of Significant Saphenous Vein Graft Lesions (NCT05187351)

🔵 Active, Not Recruiting Interventional Protocol 📊 Observational Clinical Research Sponsor: Minneapolis Heart Institute Foundation

🩺 Plain-English Summary (8th-Grade Level)

The primary study objective of the NASA registry is to evaluate the 12-month incidence of target vessel failure (TVF) in patients who present with saphenous vein graft (SVG) lesions and undergo percutaneous coronary intervention (PCI) of the corresponding native coronary artery.

Who can join: Review the eligibility criteria below.

Location: Henry Ford Health System — Detroit, Michigan

Age range: 18 Years

🧪 Interventions in This Study

  • Percutaneous coronary intervention of the native coronary artery with Synergy (PROCEDURE)

📋 "Do I Qualify?" — 1-Minute Self Screener

Instant Checklist

Full eligibility criteria are available on the official NIH protocol. View the criteria ↗

📍 All Participating Trial Locations (2 Sites)

  • Henry Ford Health System — Detroit, Michigan
  • Minneapolis Heart Institute Foundation — Minneapolis, Minnesota

💰 Cost, Insurance & Patient Rights

  • 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
  • Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
  • Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

Explore by condition: All Target Vessel Failure in Saphenous Vein Grafts clinical trials

💡 How to Participate

  1. Check the checklist above to see if you may qualify.
  2. Review the official NIH record below to find the coordinating site.
  3. Ask about the visit schedule, what is covered at no cost, and any travel support.
  4. Confirm with your own doctor before making a decision.
🏛️ View Official NIH Record ↗